InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Lian Brian, Chairman & CEO. Director active across 1 company, notably Viking Therapeutics, Inc.. Cumulatively, 25 filings have been published. Split: 0 buy · 4 sells. Total volume traded: €7.2m. Activity tracked since 28 September 2021. The latest transaction was disclosed on 28 July 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Lian Brian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
221,667 shares0Common Stock, par value $0.00001 per shareSEC:0001193125-26-324448:0
148,517 shares@ US$33.31530.12% mcap43.6% of flowCommon Stock, par value $0.00001 per shareSEC:0001193125-26-324448:1
78,400 shares0Common Stock, par value $0.00001 per shareSEC:0001193125-26-003113:0
70,084 shares0Common Stock, par value $0.00001 per shareSEC:0001193125-25-254299:0
48,333 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-25-093793:0
92,800 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-25-002487:0
166,130 shares@ US$7.7720.0% of flowCommon Stock, par value $0.00001 per shareSEC:0000950170-24-108576:0
1,000 shares@ US$7.770.1% of flowCommon Stock, par value $0.00001 per shareSEC:0000950170-24-099982:0
112,870 shares@ US$7.7713.7% of flowCommon Stock, par value $0.00001 per shareSEC:0000950170-24-098803:0
41,000 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-24-088544:0
221,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-005117:0
221,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-004233:0
45,000 shares@ US$29.9021.6% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-003068:0
49,079 shares@ US$1.231.0% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-003010:0
85,000 shares@ US$1.231.7% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-002512:0
35,000 shares@ US$1.230.7% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-002458:0
150,000 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-000931:0
45,000 shares@ US$22.4515.9% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-026356:0
35,000 shares@ US$21.4511.9% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-025277:0
125,000 shares@ US$2.154.3% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-024724:0
54,336 shares@ US$1.881.6% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-024228:0
115,852 shares@ US$1.232.3% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-022400:0
121,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-23-001340:0
36,319 shares@ US$4.881.6% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-22-001986:0
55,500 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-21-058253:0
25 of 25 declarations
About Lian Brian
Lian Brian is Président-Directeur Général and is linked to Viking Therapeutics, Inc. (XNAS) as President & CEO. He has 23 filings in total, and across the sampled recent filings the most frequent transaction nature is Attribution, with 0 EUR of buys and 2854927 EUR of sells between 2021-09-30 and 2026-01-05.
